TNDM | Tandem Diabetes CareNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$17.65
-$1.02 (-5.46%)

Tandem Diabetes Care (TNDM) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits below the 50 and the 200; on the 4-hour it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $17.65 vs 50 $17.86 / 200 $18.91
Projection
No cross projected
Test
No active test
Last cross
Death cross 13 Oct 2026 ยท projected 2 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $19.11 vs 50 $19.26 / 200 $26.75
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 7 Nov 2022 ยท projected 29 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $17.93 vs 50 $17.08 / 200 $17.98
Projection
No cross projected
Test
No active test
Last cross
Death cross 6 Oct 2026 ยท projected 28 bars out

Cross history

21
crosses on record since 2018
10 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
13 Oct 2026Death flatdaily2 bars outNot tested
6 Oct 2026Death4-hour28 bars outNot tested
23 Sep 2026Golden flatdaily5 bars outNot tested
12 Aug 2026Golden4-hour30 bars outNot tested
5 Jun 2026Death moderatedaily30 bars out3 bar cross test

About TNDM

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$35.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.